Publisher Future Science Group is making some top review and commentary articles freely available to aid the Zika research effort.
In a bid to aid the ongoing effort to develop effective treatments, and ultimately a preventative vaccine, for Zika infection, Future Science Group is making a collection of relevant articles from the journals Future Microbiology and Future Virology freely available via their website.
The Zika virus is a mosquito-borne flavivirus, capable of infecting humans, and which has emerged in recent years as a serious threat to human health. While Zika infection generally causes no-to-mild symptoms in those it infects, it has been potentially linked with neurological conditions such as Guillain–Barré syndrome in adults, and microcephaly, severe brain malformations and other birth defects in instances where Zika virus is believed to have been transmitted from a mother to her unborn fetus. There are currently no specific treatments for Zika infection (beyond managing symptoms), and no preventative vaccine is yet available.
Launched in 2006, the journals Future Microbiology and Future Virology are part of the Future Medicine journal collection. Future Microbiology is a MEDLINE-indexed journal with forward-looking focus, covering numerous medical microbiological areas, with an international Editorial Board headed by Senior Editors Professor Richard A Calderone (Georgetown University, WA, USA) and Professor B. Brett Finlay (University of British Columbia, Canada). Future Virology features the latest updates in virology, infectious disease and immunology analysis, with an international Editorial Board headed by Editor-in-Chief Mark Wainberg (McGill AIDS Centre, Canada).
Interested parties may visit http://www.future-science-group.com/zika-articles/ to download these articles.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
